AnalystsMartin FanMartin Fan's Stock Forecasts
AnalystsMartin Fan
Sectors:
Industries:
Analyst Ranking
Top 8%
#400 out of 5326 analysts
Average Return
+63.49%
Win Rate
70%21 out of 30
Risk vs Reward
Poor
Good
Martin Fan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +575.48% | $9.46 | $63.90 | 2025-05-15 - 2026-05-14 | Buy |
Aclaris Therapeutics IncACRS | +224.82% | $1.41 | $4.58 | 2025-05-28 - 2026-05-27 | Buy |
Anaptysbio IncANAB | +202.90% | $21.70 | $65.73 | 2025-05-01 - 2026-04-30 | Buy |
Oruka Therapeutics IncORKA | +195.79% | $31.34 | $92.70 | 2026-01-13 - 2026-07-17 | Buy |
Anaptysbio IncANAB | +184.73% | $20.37 | $58.00 | 2025-08-07 - 2026-07-17 | Buy |
Martin Fan Analyst Color
Get additional color on Martin Fan's coverage of popular stocks
Martin Fan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zura Bio LtdZURA | 2 | Buy | $15.00 | +175.23% | Reiterates | 19 days ago |
Cartesian Therapeutics IncRNAC | 5 | Buy | $38.00 | +360.05% | Reiterates | a month ago |
Vor Biopharma IncVOR | 3 | Hold | $18.00 | -0.50% | Maintains | 2 months ago |
Imagenebio IncIMA | 2 | Sell | $2.00 | -62.83% | Reiterates | 2 months ago |
Nektar TherapeuticsNKTR | 3 | Hold | $80.00 | +17.20% | Maintains | 2 months ago |
Artiva Biotherapeutics IncARTV | 3 | Buy | $40.00 | +309.84% | Maintains | 2 months ago |
Aclaris Therapeutics IncACRS | 3 | Buy | $10.00 | +76.06% | Maintains | 3 months ago |
Oruka Therapeutics IncORKA | 4 | Buy | $85.00 | -8.31% | Maintains | 3 months ago |
Sana Biotechnology IncSANA | 3 | Buy | $7.00 | +122.22% | Maintains | 3 months ago |
Anaptysbio IncANAB | 6 | Buy | $75.00 | +29.31% | Maintains | 4 months ago |
Zenas Biopharma IncZBIO | 2 | Buy | $45.00 | +52.39% | Reiterates | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.